[HTML][HTML] Antiphospholipid antibodies in patients with COVID‐19: a relevant observation?
KMJ Devreese, EA Linskens, D Benoit… - Journal of Thrombosis …, 2020 - Elsevier
Background High incidence of thrombosis in COVID‐19 patients indicates a
hypercoagulable state. Hence, exploring the involvement of antiphospholipid antibodies
(aPL) in these patients is of interest. Objectives To illustrate the incidence of criteria (lupus
anticoagulant [LAC], anticardiolipin [aCL] immunoglobulin G [IgG]/IgM, antibeta2‐
glycoprotein I antibodies [aβ2GPI] IgG/IgM) and noncriteria (anti‐phosphatidyl
serine/prothrombin [aPS/PT], aCL, and aβ2GPI IgA) aPL in a consecutive cohort of critically …
hypercoagulable state. Hence, exploring the involvement of antiphospholipid antibodies
(aPL) in these patients is of interest. Objectives To illustrate the incidence of criteria (lupus
anticoagulant [LAC], anticardiolipin [aCL] immunoglobulin G [IgG]/IgM, antibeta2‐
glycoprotein I antibodies [aβ2GPI] IgG/IgM) and noncriteria (anti‐phosphatidyl
serine/prothrombin [aPS/PT], aCL, and aβ2GPI IgA) aPL in a consecutive cohort of critically …